Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype

被引:33
|
作者
Bhattacharyya, D
Brooks, BR
Callahan, L
机构
[1] NIH, DIV COMP RES & TECHNOL, STRUCT BIOL LAB, BETHESDA, MD 20892 USA
[2] US PHARMACOPEIAL CONVENT INC, ROCKVILLE, MD 20852 USA
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; PRINCIPAL NEUTRALIZING DETERMINANT; HEPARAN-SULFATE PROTEOGLYCANS; BIOLOGICAL PHENOTYPE; DEXTRAN SULFATE; INFECTION; DOMAIN; GP120; PROGRESSION; CAPACITY;
D O I
10.1089/aid.1996.12.83
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although the V3 loop of the envelope glycoprotein (gp120) plays a role in determining the phenotype, pathogenesis, and tropism of human immunodeficiency virus-1 (HIV-1), there has not been any consistent correlation between structure and phenotype, Theoretically determined structures of the V3 loop of gp120, from 20 different viral strains, 10 syncytium-inducing (SI) and 10 non-syncytium-inducing (NSI) phenotype, revealed that all V3 loops from SI phenotypic strains had at least two positively charged residues in close proximity, on the same face of the loop, All of the SI phenotypic V3 loop structures were capable of forming strong divalent electrostatic interactions with disulfated sugars. The ability to form this interaction may be a determinant of the phenotype, tropism, and pathogenicity of HIV-1 viral strains, This structural motif was absent in all V3 loops from viral strains with the NSI phenotype.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 50 条
  • [31] Experimental HIV infection of human lymphoid tissue: Correlation of CD4(+) T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1
    Glushakova, S
    Baibakov, B
    Zimmerberg, J
    Margolis, LB
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (06) : 461 - 471
  • [32] HIV-1 viraemia changes in patients with and without syncytium-inducing phenotype treated with nucleoside analogues: A case-control study
    Leal, M
    Torres, Y
    Medrano, FJ
    Rey, C
    Caruz, A
    SanchezQuijano, A
    Lissen, E
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (10) : 923 - 928
  • [33] LOWER PREVALENCE AND INCIDENCE OF HIV-1 SYNCYTIUM-INDUCING PHENOTYPE AMONG INJECTING DRUG-USERS COMPARED WITH HOMOSEXUAL MEN
    SPIJKERMAN, IJB
    KOOT, M
    PRINS, M
    KEET, IPM
    VANDENHOEK, AJAR
    MIEDEMA, F
    COUTINHO, RA
    AIDS, 1995, 9 (09) : 1085 - 1092
  • [34] Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage
    Verrier, F
    Borman, AM
    Brand, D
    Girard, M
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (08) : 731 - 743
  • [35] Permissive residues within the minimal epitopes of neutralizing monoclonal antibodies to the V3 loop of HIV-1
    Laisney, IL
    Benjamin, H
    Gefter, M
    Strosberg, AD
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (07) : 1634 - 1640
  • [36] Strong association between failure of T cell homeostasis and the syncytium-inducing phenotype among HIV-1-infected men in the Amsterdam Cohort Study
    Maas, JJJ
    Gange, SJ
    Schuitemaker, H
    Coutinho, RA
    van Leeuwen, R
    Margolick, JB
    AIDS, 2000, 14 (09) : 1155 - 1161
  • [37] KILLING OF CD4 CELLS BY HIV-1 - DISCORDANCE WITH SYNCYTIA INDUCTION AND V3 LOOP PHENOTYPE
    ESSEX, M
    YU, XF
    MCLANE, MF
    LEE, TH
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S62 - S62
  • [38] Membranotropic effects of peptides from the V3 loop of HIV-1
    Sergei Andreev
    Igor Andreev
    Elena Nikolaeva
    Anna Petrukhina
    Vladimir Zemskov
    Mariam Vafina
    Letters in Peptide Science, 1998, 5 : 63 - 66
  • [39] Membranotropic effects of peptides from the V3 loop of HIV-1
    Sergei Andreev
    Igor Andreev
    Elena Nikolaeva
    Anna Petrukhina
    Vladimir Zemskov
    Mariam Vafina
    Letters in Peptide Science, 1998, 5 : 63 - 66
  • [40] Membranotropic effects of peptides from the V3 loop of HIV-1
    Andreev, S
    Andreev, I
    Nikolaeva, E
    Petrukhina, A
    Zemskov, V
    Vafina, M
    LETTERS IN PEPTIDE SCIENCE, 1998, 5 (2-3): : 63 - 66